Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure

被引:108
作者
Chandler, MP
Stanley, WC
Morita, H
Suzuki, G
Roth, BA
Blackburn, B
Wolff, A
Sabbah, HN
机构
[1] Henry Ford Heart & Vasc Inst, Dept Med, Detroit, MI 48202 USA
[2] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA
[3] CV Therapeut, Palo Alto, CA USA
关键词
heart failure; mechanical efficiency; myocardial metabolism; fatty acids;
D O I
10.1161/01.RES.0000031151.21145.59
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present study assesses whether ranolazine increases left ventricular (LV) function without an increase in myocardial oxygen consumption (M(V) over dot o(2)) and thus improves LV mechanical efficiency in dogs with heart failure (HF). Ranolazine did not change M(V) over dot O-2 and LV mechanical efficiency increased (22.4+/-2.8% to 30.9+/-3.4% (P<0.05). In contrast, dobutamine significantly increased M(V) over dot O-2 and did not improve mechanical efficiency. Thus, short-term treatment with ranolazine improved LV function without an increase in M(V) over dot O-2, resulting in an increased myocardial mechanical efficiency in dogs with HF.
引用
收藏
页码:278 / 280
页数:3
相关论文
共 22 条
[1]   The effects of β1-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction -: A double-blind, placebo-controlled, positron-emission tomography study [J].
Beanlands, RSB ;
Nahmias, C ;
Gordon, E ;
Coates, G ;
deKemp, R ;
deKemp, R ;
Firnau, G ;
Fallen, E .
CIRCULATION, 2000, 102 (17) :2070-2075
[2]   IMPROVED HEMODYNAMIC FUNCTION AND MECHANICAL EFFICIENCY IN CONGESTIVE-HEART-FAILURE WITH SODIUM DICHLOROACETATE [J].
BERSIN, RM ;
WOLFE, C ;
KWASMAN, M ;
LAU, D ;
KLINSKI, C ;
TANAKA, K ;
KHORRAMI, P ;
HENDERSON, GN ;
DEMARCO, T ;
CHATTERJEE, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) :1617-1624
[3]   UNCOUPLING ACTIVITY OF LONG-CHAIN FATTY ACIDS [J].
BORST, P ;
LOOS, JA ;
CHRIST, EJ ;
SLATER, EC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1962, 62 (03) :509-&
[4]  
BURKHOFF D, 1991, AM J PHYSIOL, V261, P741
[5]   Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy [J].
Cappola, TP ;
Kass, DA ;
Nelson, GS ;
Berger, RD ;
Rosas, GO ;
Kobeissi, ZA ;
Marbán, E ;
Hare, JM .
CIRCULATION, 2001, 104 (20) :2407-2411
[6]   THE CORONARY CIRCULATION IN THE DOG [J].
ECKENHOFF, JE ;
HAFKENSCHIEL, JH ;
LANDMESSER, CM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1947, 148 (03) :582-596
[7]   Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure [J].
Ekelund, UEG ;
Harrison, RW ;
Shokek, O ;
Thakkar, RN ;
Tunin, RS ;
Senzaki, H ;
Kass, DA ;
Marbán, E ;
Hare, JM .
CIRCULATION RESEARCH, 1999, 85 (05) :437-445
[8]   Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure:: an open study [J].
Hermann, HP ;
Pieske, B ;
Schwarzmüller, E ;
Keul, J ;
Just, H ;
Hasenfuss, G .
LANCET, 1999, 353 (9161) :1321-1323
[10]   Ranolazine: A novel metabolic modulator for the treatment of angina [J].
McCormack, JG ;
Stanley, WC ;
Wolff, AA .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 30 (05) :639-645